Most Popular Stories
- New contenders will duke it out with Vertex for the hep C crown
- Mylan snags Pfizer's Advair copy, inhaler technology
- Biotech spin-out grabs $76M in venture cash for antibiotic work
- Pharmacies accuse Pfizer, Ranbaxy of secret Lipitor deal
- Bavarian Nordic sees positive results in small therapeutic cancer vax study
- Class-action securities suit goes forward against Amgen
Featured Jobs
-
Clinical Research Coordinator
Lovelace Respiratory Research Institute - Albuquerque, NM -
Manager, Strategic Forecasting & Analytics Job
Celgene Corporation - Basking Ridge, NJ, US -
Clinical Trials Site Director
Lovelace Respiratory Research Institute - Albuquerque, NM -
Director, IT Global Operation Services, End-User Informatics Job
Celgene Corporation - Summit, NJ, US -
Principal Scientist
Watson Pharmaceuticals - Fort Lauderdale, FL
More Jobs >>
Events
- New Paradigms to Fund & Move Biotech
January 11-12, 2012 — San Francisco, CA - Health Market Science Webinar: 3 Steps to New Physician Opportunities
Nov. 17 - Life Science in the Cloud
Nov 16, 2011 — Cambridge, MA - Biomarker Applications for Improved Clinical Trial Outcomes
Nov. 15-16 — Boston
More Events >>
Biography for Erica Teichert
Erica Teichert is the associate editor of the FierceBiotech and FiercePharma publications. A San Francisco native, Erica previously interned for the Deseret News (Utah), Where Magazine (Washington, D.C.) and BYU Magazine (Utah). She has a passion for travel, ancient history and NBA basketball-especially the Cleveland Cavaliers and Utah Jazz. She is based at the FierceMarkets main office in Washington, D.C., and can be reached at [email protected]. Follow @FierceMedDev on Twitter and find her on LinkedIn.
Articles by Erica Teichert
- May 19, 2011
- May 18, 2011
- Celiac disease vax does well in Ph1; Washington pushes for higher vax rates;May 12, 2011
- GenVec and Merial enter second animal health pact; Flu vax safe for kidney transplant patients;May 5, 2011
- Sweden's Isconova buys Nordic VaccineMay 4, 2011
- Vical releases Vaxfactin results; Merck and Biogen boost NC job market;April 28, 2011
- April 28, 2011
- April 27, 2011
- Scientists study sugar-based H.pylori vax; Cancer vax market worth $3B in 2015;April 21, 2011
- April 20, 2011
- April 19, 2011
- April 14, 2011
- April 7, 2011
- Cat allergy vax looks promising; Philip Morris buys stake in Medicago; Nobel Prize-winner dies;April 7, 2011
- April 6, 2011
- CDC shortens rabies vax schedule; Bavarian Nordic applies for Imvamune Canadian marketing;March 31, 2011
- March 30, 2011
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
More Research Reports >>
